{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T21:52:52Z","timestamp":1791755572900,"version":"4.3.4"},"reference-count":104,"publisher":"Impact Journals, LLC","issue":"34","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,8,23]]},"DOI":"10.18632\/oncotarget.9908","type":"journal-article","created":{"date-parts":[[2016,6,10]],"date-time":"2016-06-10T00:35:48Z","timestamp":1465518948000},"page":"55771-55788","source":"Crossref","is-referenced-by-count":101,"title":["Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer"],"prefix":"10.18632","volume":"7","author":[{"given":"Junli","family":"Deng","sequence":"first","affiliation":[{"name":"Cancer Care Centre, St George Hospital, Kogarah, NSW, Australia"},{"name":"St George and Sutherland Clinical School, University of New South Wales (UNSW), Kensington, NSW, Australia"},{"name":"Department of Gynecological Oncology, Henan Cancer Hospital, Zhengzhou, Henan, China"},{"name":"Zhengzhou University, Zhengzhou, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Gynecological Oncology, Henan Cancer Hospital, Zhengzhou, Henan, China"},{"name":"Zhengzhou University, Zhengzhou, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Gynecological Oncology, Henan Cancer Hospital, Zhengzhou, Henan, China"},{"name":"Zhengzhou University, Zhengzhou, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingli","family":"Hao","sequence":"additional","affiliation":[{"name":"Cancer Care Centre, St George Hospital, Kogarah, NSW, Australia"},{"name":"St George and Sutherland Clinical School, University of New South Wales (UNSW), Kensington, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ni","sequence":"additional","affiliation":[{"name":"Cancer Care Centre, St George Hospital, Kogarah, NSW, Australia"},{"name":"St George and Sutherland Clinical School, University of New South Wales (UNSW), Kensington, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chang","sequence":"additional","affiliation":[{"name":"Cancer Care Centre, St George Hospital, Kogarah, NSW, Australia"},{"name":"St George and Sutherland Clinical School, University of New South Wales (UNSW), Kensington, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Duan","sequence":"additional","affiliation":[{"name":"School of Medicine, Deakin University, Waurn Ponds, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Graham","sequence":"additional","affiliation":[{"name":"Cancer Care Centre, St George Hospital, Kogarah, NSW, Australia"},{"name":"St George and Sutherland Clinical School, University of New South Wales (UNSW), Kensington, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Li","sequence":"additional","affiliation":[{"name":"Cancer Care Centre, St George Hospital, Kogarah, NSW, Australia"},{"name":"St George and Sutherland Clinical School, University of New South Wales (UNSW), Kensington, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,6,9]]},"reference":[{"key":"1","first-page":"87","article-title":"Global cancer statistics 2012","volume":"65","author":"Jemal","year":"2015","journal-title":"CA"},{"key":"2","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/AOG.0b013e318264f794","article-title":"Ten-year relative survival for epithelial ovarian cancer","volume":"120","author":"Seamon","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"Suppl 1","key":"3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/ijgc-00009577-200505001-00002","article-title":"Treatment goals in ovarian cancer","volume":"15","author":"Ozols","year":"2005","journal-title":"International journal of gynecological cancer"},{"key":"4","first-page":"33","article-title":"Epithelial-mesenchymal transition in ovarian carcinoma","volume":"2","author":"Reich","year":"2012","journal-title":"Front Oncol"},{"key":"5","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ejca.2012.06.026","article-title":"Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer","volume":"49","author":"Signorelli","year":"2013","journal-title":"Eur J Cancer"},{"key":"6","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1158\/1078-0432.CCR-11-2188","article-title":"Stem cell pathways contribute to clinical chemoresistance in ovarian cancer","volume":"18","author":"Landen","year":"2012","journal-title":"Clin Cancer Res"},{"key":"7","doi-asserted-by":"publisher","first-page":"7260","DOI":"10.18632\/oncotarget.2428","article-title":"TWIST and ovarian cancer stem cells: implications for chemoresistance and metastasis","volume":"5","author":"Yin","year":"2014","journal-title":"Oncotarget"},{"key":"8","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nrm3758","article-title":"Molecular mechanisms of epithelial-mesenchymal transition","volume":"15","author":"Derynck","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","article-title":"Epithelial-mesenchymal transitions in development and disease","volume":"139","author":"Nieto","year":"2009","journal-title":"Cell"},{"key":"10","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1172\/JCI39675","article-title":"EMT: when epithelial cells decide to become mesenchymal-like cells","volume":"119","author":"Kalluri","year":"2009","journal-title":"J Clin Invest"},{"key":"11","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1172\/JCI36183","article-title":"Biomarkers for epithelial-mesenchymal transitions","volume":"119","author":"Neilson","year":"2009","journal-title":"J Clin Invest"},{"key":"12","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.ygyno.2013.09.034","article-title":"The Wnt\/beta-catenin pathway in ovarian cancer: a review","volume":"131","author":"Buchsbaum","year":"2013","journal-title":"Gynecologic oncology"},{"key":"13","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/jb\/mvr044","article-title":"Cancer early dissemination: cancerous epithelial-mesenchymal transdifferentiation and transforming growth factor beta signalling","volume":"149","author":"Sabe","year":"2011","journal-title":"J Biochem"},{"key":"14","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/labinvest.2010.201","article-title":"Slug enhances invasion ability of pancreatic cancer cells through upregulation of matrix metalloproteinase-9 and actin cytoskeleton remodeling","volume":"91","author":"Wang","year":"2011","journal-title":"Lab Invest"},{"key":"15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.canlet.2009.09.017","article-title":"Epithelial-mesenchymal transition in ovarian cancer","volume":"291","author":"Salzet","year":"2010","journal-title":"Cancer Lett"},{"key":"16","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1159\/000107108","article-title":"Twist expression predicts poor clinical outcome of patients with clear cell carcinoma of the ovary","volume":"71","author":"Kikkawa","year":"2006","journal-title":"Oncology"},{"key":"17","doi-asserted-by":"crossref","first-page":"669","DOI":"10.7314\/APJCP.2013.14.2.669","article-title":"Expression and significance of twist and E-cadherin in ovarian cancer tissues","volume":"14","author":"Hou","year":"2013","journal-title":"Asian Pac J Cancer Prev"},{"key":"18","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1757-2215-7-76","article-title":"The EMT (epithelial-mesenchymal-transition)-related protein expression indicates the metastatic status and prognosis in patients with ovarian cancer","volume":"7","author":"Ohmichi","year":"2014","journal-title":"J Ovarian Res"},{"key":"19","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1097\/IGC.0b013e3182a5e760","article-title":"Effect of down-regulated transcriptional repressor ZEB1 on the epithelial-mesenchymal transition of ovarian cancer cells","volume":"23","author":"Dou","year":"2013","journal-title":"International journal of gynecological cancer"},{"key":"20","first-page":"277","article-title":"Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells","volume":"31","author":"Kikkawa","year":"2007","journal-title":"Int J Oncol"},{"key":"21","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1002\/jcb.23199","article-title":"Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile","volume":"112","author":"Ahmed","year":"2011","journal-title":"J Cell Biochem"},{"key":"22","doi-asserted-by":"publisher","first-page":"40005","DOI":"10.18632\/oncotarget.5552","article-title":"A multi-stage process including transient polyploidization and EMT precedes the emergence of chemoresistent ovarian carcinoma cells with a dedifferentiated and pro-inflammatory secretory phenotype","volume":"6","author":"Muller","year":"2015","journal-title":"Oncotarget"},{"key":"23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1471-2407-12-91","article-title":"EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer","volume":"12","author":"Feilotter","year":"2012","journal-title":"BMC Cancer"},{"key":"24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2014.10.004","article-title":"The clinical role of epithelial-mesenchymal transition and stem cell markers in advanced-stage ovarian serous carcinoma effusions","volume":"46","author":"Thiery","year":"2015","journal-title":"Hum Pathol"},{"key":"25","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1002\/stem.154","article-title":"Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells","volume":"27","author":"Bapat","year":"2009","journal-title":"Stem Cells"},{"key":"26","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1038\/onc.2011.409","article-title":"Hyperactive EGF receptor Jaks and Stat3 signaling promote enhanced colony-forming ability motility and migration of cisplatin-resistant ovarian cancer cells","volume":"31","author":"Turkson","year":"2012","journal-title":"Oncogene"},{"key":"27","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ygyno.2013.03.019","article-title":"Notch3 induces epithelial-mesenchymal transition and attenuates carboplatin-induced apoptosis in ovarian cancer cells","volume":"130","author":"Fu","year":"2013","journal-title":"Gynecologic oncology"},{"key":"28","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1101\/gad.1640608","article-title":"The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2","volume":"22","author":"Peter","year":"2008","journal-title":"Genes Dev"},{"key":"29","first-page":"85","article-title":"The miR-200 family controls beta-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients","volume":"18","author":"Rodriguez-Antona","year":"2011","journal-title":"Endocr Relat Cancer"},{"key":"30","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.molonc.2015.04.015","article-title":"The miR-200 family differentially regulates sensitivity to paclitaxel and carboplatin in human ovarian carcinoma OVCAR-3 and MES-OV cells","volume":"9","author":"Sikic","year":"2015","journal-title":"Mol Oncol"},{"key":"31","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3892\/or.2013.2567","article-title":"Acquisition of paclitaxel resistance via PI3Kdependent epithelialmesenchymal transition in A2780 human ovarian cancer cells","volume":"30","author":"Hua","year":"2013","journal-title":"Oncol Rep"},{"key":"32","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/ijc.25083","article-title":"Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresistance of ovarian cancer through Wnt signaling pathway","volume":"127","author":"Yu","year":"2010","journal-title":"Int J Cancer"},{"key":"33","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/bjc.2013.10","article-title":"Anticancer efficacy of cisplatin and trichostatin A or 5-aza-2\u2032-deoxycytidine on ovarian cancer","volume":"108","author":"Brewer","year":"2013","journal-title":"Br J Cancer"},{"key":"34","article-title":"miR-186 regulation of Twist1 and ovarian cancer sensitivity to cisplatin","author":"Li","year":"2015","journal-title":"Oncogene"},{"key":"35","first-page":"107","article-title":"Augmentation of response to chemotherapy by microRNA-506 through regulation of RAD51 in serous ovarian cancers","author":"Chen","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"36","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.18632\/oncotarget.2957","article-title":"FOXM1 confers to epithelial-mesenchymal transition stemness and chemoresistance in epithelial ovarian carcinoma cells","volume":"6","author":"Chou","year":"2015","journal-title":"Oncotarget"},{"key":"37","doi-asserted-by":"publisher","first-page":"6453","DOI":"10.18632\/oncotarget.2203","article-title":"Sensitization of ovarian cancer cells to cisplatin by gold nanoparticles","volume":"5","author":"Mukherjee","year":"2014","journal-title":"Oncotarget"},{"key":"38","doi-asserted-by":"crossref","first-page":"7453","DOI":"10.1158\/0008-5472.CAN-13-3133","article-title":"Endothelin A receptor\/beta-arrestin signaling to the Wnt pathway renders ovarian cancer cells resistant to chemotherapy","volume":"74","author":"Bagnato","year":"2014","journal-title":"Cancer research"},{"key":"39","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nbt0109-44","article-title":"Looking ahead in cancer stem cell research","volume":"27","author":"Dick","year":"2009","journal-title":"Nat Biotechnol"},{"key":"40","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/embr.201338254","article-title":"Dedifferentiation and reprogramming: origins of cancer stem cells","volume":"15","author":"Verma","year":"2014","journal-title":"EMBO Rep"},{"key":"41","first-page":"1101","article-title":"Cancer stem cells: implications for cancer therapy","volume":"28","author":"Cristofanilli","year":"2014","journal-title":"Oncology (Williston Park)"},{"key":"42","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1158\/0008-5472.CAN-08-0364","article-title":"Identification and characterization of ovarian cancer-initiating cells from primary human tumors","volume":"68","author":"Nephew","year":"2008","journal-title":"Cancer research"},{"key":"43","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/onc.2008.374","article-title":"Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells","volume":"28","author":"Murphy","year":"2009","journal-title":"Oncogene"},{"key":"44","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1002\/stem.236","article-title":"CD133 expression defines a tumor initiating cell population in primary human ovarian cancer","volume":"27","author":"Foster","year":"2009","journal-title":"Stem Cells"},{"key":"45","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1158\/0008-5472.CAN-04-3931","article-title":"Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer","volume":"65","author":"Kurrey","year":"2005","journal-title":"Cancer research"},{"key":"46","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1146\/annurev.cellbio.22.010305.104154","article-title":"The biology of cancer stem cells","volume":"23","author":"Clarke","year":"2007","journal-title":"Annu Rev Cell Dev Biol"},{"key":"47","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/mp.52.4.189","article-title":"CD44 cell adhesion molecules","volume":"52","author":"Tarin","year":"1999","journal-title":"Mol Pathol"},{"key":"48","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4161\/cc.8.1.7533","article-title":"Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance","volume":"8","author":"Mor","year":"2009","journal-title":"Cell Cycle"},{"key":"49","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.pai.0000173054.83414.22","article-title":"KIT (CD117): a review on expression in normal and neoplastic tissues and mutations and their clinicopathologic correlation","volume":"13","author":"Lasota","year":"2005","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"50","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.yexmp.2011.06.005","article-title":"Ovarian cancer cells with the CD117 phenotype are highly tumorigenic and are related to chemotherapy outcome","volume":"91","author":"Shen","year":"2011","journal-title":"Exp Mol Pathol"},{"key":"51","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1038\/onc.2012.290","article-title":"c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt\/beta-catenin-ATP-binding cassette G2 signaling","volume":"32","author":"Wong","year":"2013","journal-title":"Oncogene"},{"key":"52","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.bbrc.2007.01.159","article-title":"Tumour-initiating cells vs cancer \u2018stem\u2019 cells and CD133: what's in the name?","volume":"355","author":"Ralph","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"53","doi-asserted-by":"crossref","first-page":"e99412","DOI":"10.1371\/journal.pone.0099412","article-title":"Identification of CD24 as a cancer stem cell marker in human nasopharyngeal carcinoma","volume":"9","author":"Lai","year":"2014","journal-title":"PLoS One"},{"key":"54","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1158\/0008-5472.CAN-06-2030","article-title":"Identification of pancreatic cancer stem cells","volume":"67","author":"Simeone","year":"2007","journal-title":"Cancer research"},{"key":"55","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1038\/onc.2010.35","article-title":"CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells","volume":"29","author":"Cho","year":"2010","journal-title":"Oncogene"},{"key":"56","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1158\/1535-7163.MCT-14-0607","article-title":"CD24+ Ovarian Cancer Cells Are Enriched for Cancer-Initiating Cells and Dependent on JAK2 Signaling for Growth and Metastasis","volume":"14","author":"Buckanovich","year":"2015","journal-title":"Mol Cancer Ther"},{"key":"57","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s10585-012-9482-4","article-title":"CD44+\/CD24- ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival","volume":"29","author":"Rocconi","year":"2012","journal-title":"Clin Exp Metastasis"},{"key":"58","first-page":"3","article-title":"An emerging question about putative cancer stem cells in established cell lines-are they true stem cells or a fluctuating cell phenotype?","author":"Ratajczak","year":"2015","journal-title":"Journal of cancer stem cell research"},{"key":"59","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.4161\/cc.10.9.15486","article-title":"Aldehyde dehydrogenase: its role as a cancer stem cell marker comes down to the specific isoform","volume":"10","author":"Lee","year":"2011","journal-title":"Cell Cycle"},{"key":"60","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/sj.leu.2404721","article-title":"Aldehyde dehydrogenase activity in leukemic blasts defines a subgroup of acute myeloid leukemia with adverse prognosis and superior NOD\/SCID engrafting potential","volume":"21","author":"Leung","year":"2007","journal-title":"Leukemia"},{"key":"61","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1158\/1535-7163.MCT-10-0563","article-title":"Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer","volume":"9","author":"Sood","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"62","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1158\/0008-5472.CAN-10-3175","article-title":"Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival","volume":"71","author":"Buckanovich","year":"2011","journal-title":"Cancer research"},{"key":"63","doi-asserted-by":"crossref","first-page":"e81050","DOI":"10.1371\/journal.pone.0081050","article-title":"Prognostic value of cancer stem cell marker aldehyde dehydrogenase in ovarian cancer: a meta-analysis","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"64","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ygyno.2014.12.005","article-title":"Cancer stem-like cells of ovarian clear cell carcinoma are enriched in the ALDH-high population associated with an accelerated scavenging system in reactive oxygen species","volume":"137","author":"Morishige","year":"2015","journal-title":"Gynecologic oncology"},{"key":"65","article-title":"High Expressions of Lgr5 and ALDH1 in Primary Epithelial Ovarian Cancer Correlate with Advanced Tumor Stage and Grade as well as Poor Prognosis of the Patients","author":"Wu","year":"2015","journal-title":"Gynecol Obstet Invest"},{"key":"66","doi-asserted-by":"crossref","first-page":"5627","DOI":"10.1158\/0008-5472.CAN-09-0654","article-title":"The emerging role of EpCAM in cancer and stem cell signaling","volume":"69","author":"Gires","year":"2009","journal-title":"Cancer research"},{"key":"67","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1073\/pnas.1120733109","article-title":"Human ovarian cancer stem\/progenitor cells are stimulated by doxorubicin but inhibited by Mullerian inhibiting substance","volume":"109","author":"Wei","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"68","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/IGC.0b013e3181a8331f","article-title":"Overexpression of epithelial cell adhesion molecule in primary metastatic and recurrent\/chemotherapy-resistant epithelial ovarian cancer: implications for epithelial cell adhesion molecule-specific immunotherapy","volume":"19","author":"Santin","year":"2009","journal-title":"International journal of gynecological cancer"},{"key":"69","doi-asserted-by":"publisher","first-page":"7027","DOI":"10.18632\/oncotarget.2053","article-title":"The side population of ovarian cancer cells defines a heterogeneous compartment exhibiting stem cell characteristics","volume":"5","author":"Sopper","year":"2014","journal-title":"Oncotarget"},{"key":"70","doi-asserted-by":"crossref","first-page":"11154","DOI":"10.1073\/pnas.0603672103","article-title":"Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness","volume":"103","author":"Donahoe","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"71","doi-asserted-by":"crossref","first-page":"e84941","DOI":"10.1371\/journal.pone.0084941","article-title":"Ovarian cancer spheroid cells with stem cell-like properties contribute to tumor generation metastasis and chemotherapy resistance through hypoxia-resistant metabolism","volume":"9","author":"Odunsi","year":"2014","journal-title":"PLoS One"},{"key":"72","volume-title":"StemBook","author":"Donahoe","year":"2008"},{"key":"73","doi-asserted-by":"crossref","first-page":"18874","DOI":"10.1073\/pnas.1012667107","article-title":"Mullerian inhibiting substance preferentially inhibits stem\/progenitors in human ovarian cancer cell lines compared with chemotherapeutics","volume":"107","author":"Donahoe","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"74","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nature11979","article-title":"Ovarian surface epithelium at the junction area contains a cancer-prone stem cell niche","volume":"495","author":"Nikitin","year":"2013","journal-title":"Nature"},{"key":"75","doi-asserted-by":"crossref","first-page":"e68187","DOI":"10.1371\/journal.pone.0068187","article-title":"Ovarian cancer stem cells are enriched in side population and aldehyde dehydrogenase bright overlapping population","volume":"8","author":"Sato","year":"2013","journal-title":"PLoS One"},{"key":"76","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ygyno.2010.12.366","article-title":"Side population is increased in paclitaxel-resistant ovarian cancer cell lines regardless of resistance to cisplatin","volume":"121","author":"Kiguchi","year":"2011","journal-title":"Gynecologic oncology"},{"key":"77","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1172\/JCI41004","article-title":"The therapeutic promise of the cancer stem cell concept","volume":"120","author":"Frank","year":"2010","journal-title":"J Clin Invest"},{"key":"78","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3390\/cancers30100716","article-title":"Cancer Stem Cells and Epithelial-to-Mesenchymal Transition (EMT)-Phenotypic Cells: Are They Cousins or Twins?","volume":"3","author":"Sarkar","year":"2011","journal-title":"Cancers (Basel)"},{"key":"79","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ygyno.2014.10.024","article-title":"Predictive markers of chemoresistance in advanced stages epithelial ovarian carcinoma","volume":"136","author":"Touboul","year":"2015","journal-title":"Gynecologic oncology"},{"key":"80","doi-asserted-by":"publisher","first-page":"9313","DOI":"10.18632\/oncotarget.3220","article-title":"Up-regulation of CD44 in the development of metastasis recurrence and drug resistance of ovarian cancer","volume":"6","author":"Duan","year":"2015","journal-title":"Oncotarget"},{"key":"81","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/modpathol.2011.170","article-title":"CD133 expression associated with poor prognosis in ovarian cancer","volume":"25","author":"Liu","year":"2012","journal-title":"Mod Pathol"},{"key":"82","first-page":"745","article-title":"Expression of CD 133 and CD 117 in 64 Serous Ovarian Cancer Cases","volume":"39","author":"\u0160temberger-Papi","year":"2015","journal-title":"Coll Antropol"},{"key":"83","first-page":"2745","article-title":"CD24 COX-2 and p53 in epithelial ovarian cancer and its clinical significance","volume":"4","author":"Lu","year":"2012","journal-title":"Front Biosci (Elite Ed)"},{"key":"84","first-page":"51891","article-title":"Enrichment for chemoresistant ovarian cancer stem cells from human cell lines","author":"Cowden","year":"2014","journal-title":"J Vis Exp"},{"key":"85","first-page":"75","article-title":"Targeted Disruption of the JAK2\/STAT3 Pathway in Combination with Systemic Administration of Paclitaxel Inhibits the Priming of Ovarian Cancer Stem Cells Leading to a Reduced Tumor Burden","volume":"4","author":"Ahmed","year":"2014","journal-title":"Front Oncol"},{"key":"86","doi-asserted-by":"crossref","first-page":"6624","DOI":"10.3390\/ijms14046624","article-title":"Regulation of ovarian cancer stem cells or tumor-initiating cells","volume":"14","author":"Shin","year":"2013","journal-title":"Int J Mol Sci"},{"key":"87","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1476-4598-12-24","article-title":"Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden","volume":"12","author":"Ahmed","year":"2013","journal-title":"Mol Cancer"},{"key":"88","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.stem.2009.01.007","article-title":"PTEN\/PI3K\/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells","volume":"4","author":"Holland","year":"2009","journal-title":"Cell stem cell"},{"key":"89","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.4161\/cc.20308","article-title":"Ovarian carcinoma tumor-initiating cells have a mesenchymal phenotype","volume":"11","author":"Damia","year":"2012","journal-title":"Cell Cycle"},{"key":"90","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1182\/blood-2006-05-024687","article-title":"Characterization of stem cell-like cancer cells in immune-competent mice","volume":"108","author":"Reisfeld","year":"2006","journal-title":"Blood"},{"key":"91","doi-asserted-by":"crossref","first-page":"4411","DOI":"10.1073\/pnas.1421365112","article-title":"Enhanced expression of DNA polymerase eta contributes to cisplatin resistance of ovarian cancer stem cells","volume":"112","author":"Wang","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"92","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1038\/onc.2014.296","article-title":"p53 protein aggregation promotes platinum resistance in ovarian cancer","volume":"34","author":"Mor","year":"2015","journal-title":"Oncogene"},{"key":"93","first-page":"568","article-title":"A phase 2 trial of oral imatinib in patients with epithelial ovarian fallopian tube or peritoneal carcinoma in second or greater remission","volume":"29","author":"Sabbatini","year":"2008","journal-title":"European journal of gynaecological oncology"},{"key":"94","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1200\/JCO.2007.14.3420","article-title":"Phase II evaluation of imatinib mesylate in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group Study","volume":"26","author":"Vanderhyden","year":"2008","journal-title":"Journal of clinical oncology"},{"key":"95","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ygyno.2005.09.041","article-title":"Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant epithelial ovarian and primary peritoneal cancers","volume":"101","author":"Gershenson","year":"2006","journal-title":"Gynecologic oncology"},{"key":"96","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.1525-1438.2007.00882.x","article-title":"Phase II trial of imatinib mesylate in recurrent biomarker positive ovarian cancer (Southwest Oncology Group Protocol S0211)","volume":"17","author":"Markman","year":"2007","journal-title":"International journal of gynecological cancer"},{"key":"97","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ygyno.2013.05.027","article-title":"Targeting CD133 in anovarian cancer model reduces ovarian cancer progression","volume":"130","author":"Vallera","year":"2013","journal-title":"Gynecologic oncology"},{"key":"98","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1158\/0008-5472.CAN-14-1223","article-title":"PI3K\/mTOR dual inhibitor VS-5584 preferentially targets cancer stem cells","volume":"75","author":"Xu","year":"2015","journal-title":"Cancer research"},{"key":"99","doi-asserted-by":"publisher","first-page":"13255","DOI":"10.18632\/oncotarget.3658","article-title":"Bruton's tyrosine kinase (Btk) inhibitor ibrutinib suppresses stem-like traits in ovarian cancer","volume":"6","author":"Yeh","year":"2015","journal-title":"Oncotarget"},{"key":"100","doi-asserted-by":"crossref","first-page":"E2939","DOI":"10.1073\/pnas.1206400109","article-title":"Targeting Notch a key pathway for ovarian cancer stem cells sensitizes tumors to platinum therapy","volume":"109","author":"Muto","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"101","doi-asserted-by":"crossref","first-page":"4922","DOI":"10.1158\/0008-5472.CAN-14-1022","article-title":"Epigenetic targeting of ovarian cancer stem cells","volume":"74","author":"Matei","year":"2014","journal-title":"Cancer research"},{"key":"102","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.7150\/jca.12738","article-title":"Solanum Incanum Extract Downregulates Aldehyde Dehydrogenase 1-Mediated Stemness and Inhibits Tumor Formation in Ovarian Cancer Cells","volume":"6","author":"Chou","year":"2015","journal-title":"J Cancer"},{"key":"103","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.canlet.2012.11.032","article-title":"RNA aptamers targeting cancer stem cell marker CD133","volume":"330","author":"Duan","year":"2013","journal-title":"Cancer Lett"},{"key":"104","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.7150\/thno.11692","article-title":"EpCAM Aptamer-mediated Survivin Silencing Sensitized Cancer Stem Cells to Doxorubicin in a Breast Cancer Model","volume":"5","author":"Shigdar","year":"2015","journal-title":"Theranostics"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.9908","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T07:21:02Z","timestamp":1656660062000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.9908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,9]]},"references-count":104,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2016,8,23]]}},"alternative-id":["9908","27304054"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.9908","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,9]]}}}